Incannex Healthcare (IXHL) filed a registration statement with the US Securities and Exchange Commission for the sale of 66 million shares by selling shareholders.

The prospectus covers 9.69 million shares of common stock held by the selling investors, 1.89 million shares issuable on the exercise of prefunded warrants, and 54.4 million shares issuable on the exercise of series A common stock warrants, the company said Monday in the regulatory filing.

The company won't receive any proceeds from the sale of shares, and any proceeds from the exercise of warrants will be used for working capital and general corporate purposes.